Targeting programmed cell death protein-1 (PD-1) and its ligand (PD-L) has been an important immunotherapy strategy in facilitating chronic infection and tumor progression through immunoregulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results